TR200001713T2 - Farmasötik bileşimler. - Google Patents

Farmasötik bileşimler.

Info

Publication number
TR200001713T2
TR200001713T2 TR2000/01713T TR200001713T TR200001713T2 TR 200001713 T2 TR200001713 T2 TR 200001713T2 TR 2000/01713 T TR2000/01713 T TR 2000/01713T TR 200001713 T TR200001713 T TR 200001713T TR 200001713 T2 TR200001713 T2 TR 200001713T2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
zafirculasta
sprinkling
drink
food
Prior art date
Application number
TR2000/01713T
Other languages
English (en)
Inventor
Jane Corvari Susan
Richard Creekmore Joseph
Original Assignee
Astrazeneca Uk Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Limited filed Critical Astrazeneca Uk Limited
Publication of TR200001713T2 publication Critical patent/TR200001713T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Lökotrien antagonisti zafirkulasta iliskin farmasötik bilesimlerin hazirlanmasi için bir tabakalama islemidir. Islem yiyecek ve içecek üzerine serpilmeye uygun kaplanmis boncuklar olusturmaktadir.
TR2000/01713T 1997-12-18 1998-12-15 Farmasötik bileşimler. TR200001713T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726735.5A GB9726735D0 (en) 1997-12-18 1997-12-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
TR200001713T2 true TR200001713T2 (tr) 2000-10-23

Family

ID=10823809

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01713T TR200001713T2 (tr) 1997-12-18 1998-12-15 Farmasötik bileşimler.

Country Status (30)

Country Link
US (1) US6399104B1 (tr)
EP (1) EP1041966B1 (tr)
JP (1) JP2001526206A (tr)
KR (1) KR20010033206A (tr)
CN (1) CN1282244A (tr)
AR (1) AR017884A1 (tr)
AT (1) ATE243999T1 (tr)
AU (1) AU744326C (tr)
BR (1) BR9813666A (tr)
CA (1) CA2313163A1 (tr)
DE (1) DE69816124T2 (tr)
DK (1) DK1041966T3 (tr)
EE (1) EE04260B1 (tr)
ES (1) ES2202915T3 (tr)
GB (1) GB9726735D0 (tr)
HU (1) HUP0004669A3 (tr)
ID (1) ID25857A (tr)
IL (1) IL136501A0 (tr)
IN (1) IN191311B (tr)
MY (1) MY133096A (tr)
NO (1) NO20003141L (tr)
NZ (1) NZ504566A (tr)
PL (1) PL341736A1 (tr)
PT (1) PT1041966E (tr)
RU (1) RU2205006C2 (tr)
SK (1) SK9402000A3 (tr)
TR (1) TR200001713T2 (tr)
UA (1) UA62991C2 (tr)
WO (1) WO1999032082A2 (tr)
ZA (1) ZA9811532B (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO319624B1 (no) 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
WO2008021347A2 (en) * 2006-08-16 2008-02-21 Novartis Ag Method for making solid dispersions of highly crystalline therapeutic compounds
CA2684655A1 (en) * 2007-03-26 2008-10-02 Teikoku Seiyaku Co., Ltd. Oral pharmaceutical preparation for colon-specific delivery
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
WO2018140858A1 (en) 2017-01-30 2018-08-02 Western New England University Thiol isomerases inhibitors and use thereof
CN107714694A (zh) * 2017-11-01 2018-02-23 天津国际生物医药联合研究院 扎鲁司特在抗结核分枝杆菌感染中的应用
CA3219671A1 (en) 2021-05-19 2022-11-24 Thomas Christian Lines Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis
WO2023214391A1 (en) 2022-05-06 2023-11-09 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
AR017884A1 (es) 2001-10-24
EP1041966A2 (en) 2000-10-11
KR20010033206A (ko) 2001-04-25
NO20003141D0 (no) 2000-06-16
WO1999032082A3 (en) 1999-09-16
EE200000330A (et) 2001-08-15
WO1999032082A2 (en) 1999-07-01
UA62991C2 (en) 2004-01-15
IL136501A0 (en) 2001-06-14
BR9813666A (pt) 2000-10-10
CN1282244A (zh) 2001-01-31
SK9402000A3 (en) 2001-01-18
DE69816124D1 (de) 2003-08-07
NZ504566A (en) 2002-10-25
MY133096A (en) 2007-10-31
ZA9811532B (en) 1999-06-18
JP2001526206A (ja) 2001-12-18
EP1041966B1 (en) 2003-07-02
DK1041966T3 (da) 2003-10-06
EE04260B1 (et) 2004-04-15
AU1571199A (en) 1999-07-12
PT1041966E (pt) 2003-11-28
CA2313163A1 (en) 1999-07-01
HUP0004669A3 (en) 2005-03-29
AU744326B2 (en) 2002-02-21
ATE243999T1 (de) 2003-07-15
DE69816124T2 (de) 2004-05-06
ES2202915T3 (es) 2004-04-01
AU744326C (en) 2002-11-07
GB9726735D0 (en) 1998-02-18
NO20003141L (no) 2000-06-16
IN191311B (tr) 2003-11-22
PL341736A1 (en) 2001-05-07
HUP0004669A1 (hu) 2001-08-28
ID25857A (id) 2000-11-09
RU2205006C2 (ru) 2003-05-27
US6399104B1 (en) 2002-06-04

Similar Documents

Publication Publication Date Title
DE69840277D1 (de) Dosierungsform eines Pulveragglomerates
EP1193270A3 (en) Pyrrolobenzodiazepines
AU7703898A (en) Non-competitive threshold ligand-receptor assays
TR200001713T2 (tr) Farmasötik bileşimler.
HUP0004490A2 (en) Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threoning kinase inhibitors and pharmaceutical compositions containing them
IL122861A0 (en) Film coating compositions based on dextrin and methods of coating utilizing the same
DE69514179T2 (de) Pulverlackzusammensetzung beständig gegen Unverträglichkeitsdefekte beim Übersprühen
IL133883A0 (en) Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents
FI961628A0 (fi) Indolijohdannaisia NMDA-antagonisteina
NZ333514A (en) Oral pharmaceutical composition comprising a triazole antifungal compound
NO981396D0 (no) Tetrahydroquinoliner som NMDA antagonister
AU3654200A (en) Clean combustion of coal, utility of the concomitant product of the clean combustion and the product by using the concomitant product
HUP9900071A3 (en) Tribenzimidazoles useful as topoisomerase i inhibitors, pharmaceutical compositions containing them and their use
AU8405598A (en) Assay to detect inhibitors of i-kappa-b proteolyse
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
AU6166299A (en) Dynamic creation of acpi apic tables using mp specification
HUP9801712A3 (en) Pharmaceutical compositions containing cilansetron stabilized against racemisation, their production and use of stobilizing additive agents
AU2517399A (en) Utilization of substituted sulfonamides as antiviral agents and novel substances
AU1193199A (en) Arylpiperazines as serotonin reuptake inhibitors and 5-ht1dalpha antagonists
AU3904289A (en) Secondary polyetheramines, their production and use for the production of polyureas
IT215736Z2 (it) Manufatto per la realizzazione istantanea di fiocchi decorativi e simili.
AU2852089A (en) Intermediates useful in the preparation of amino thiol dipeptides
GR3019772T3 (en) Dihydroquinoline NMDA antagonists
AU7165196A (en) Symmetrical bisheteroaryl-methoxyphenyl-iminoxyalkyl-carboxylates, their preparation and their use as inhibitors of leukotriene biosynthesis